Daxor Corp
NASDAQ:DXR
Daxor Corp
Revenue
Daxor Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Daxor Corp
NASDAQ:DXR
|
Revenue
$163.4k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-22%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Daxor Corp's Revenue?
Revenue
163.4k
USD
Based on the financial report for Dec 31, 2023, Daxor Corp's Revenue amounts to 163.4k USD.
What is Daxor Corp's Revenue growth rate?
Revenue CAGR 10Y
-22%
Over the last year, the Revenue growth was -29%. The average annual Revenue growth rates for Daxor Corp have been -14% over the past three years , -18% over the past five years , and -22% over the past ten years .